ResourceLife Sciences
Determination of amino acids for myocardial infarction and diabetes type 2
21 Jan 2021In this application note, MembraPure GmbH demonstrates a method for the determination of amino acids, such as homocysteine, which at elevated levels is a known marker of risk of cardiovascular disease.
Related Products
Request Quote for All Products
ARACUS – Amino Acid Analyzer
MembraPure GmbHThe high-end amino acid analyzer operates in the following areas: research, food quality control (own patent 10 2016 010 887), beverages, and feedstuff, and in the clinical laboratory.